H
HeyPsych
PsychTrails™TreatmentsConditionsResourcesFor CliniciansAbout

Stay updated on mental health treatments

Get the latest research, treatment updates, and evidence-based insights delivered to your inbox. No spam, just valuable mental health information.

Coming Soon

Newsletter subscription will be available soon.

H
HeyPsych

Evidence-based mental health treatment education platform. Helping you make informed decisions about your mental health journey.

Treatments

  • Medications
  • Interventional
  • Investigational
  • Alternative
  • Therapy
  • Supplements

Conditions

  • Depression
  • Anxiety
  • ADHD
  • Bipolar
  • All Conditions

Resources

  • Assessments & Screeners
  • Support & Community
  • Digital Tools
  • Knowledge Hub
  • PsychTrails™

Company

  • About Us
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 HeyPsych (PsychTrails™). All rights reserved.

Made with for better mental health
v2.2.0

Fluvoxamine (Luvox)

Introduced 1994

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published January 28, 2026•Updated January 28, 2026•Reviewed January 28, 2026

Clinical summary for Fluvoxamine (Luvox): Fluvoxamine is a daily SSRI that’s most useful for OCD and can also help certain anxiety disorders. It doesn’t work instantly—most people notice early shifts in 1-2 weeks, with bigger gains over 4-6+ weeks (and sometimes longer for OCD). The first couple weeks can feel rocky (nausea, sleep changes, jittery energy). It has a boxed warning for increased suicidal thinking/behavior in younger patients early on, and it interacts with a lot of meds because it blocks multiple liver enzymes.

What It's Used For

Fluvoxamine (Luvox) is an SSRI that’s most clearly in its lane for OCD. In psychiatry, it’s also used off-label for anxiety-spectrum conditions where obsessive, intrusive, or panic-style symptoms are driving the suffering. It’s not a quick fix—this is a daily medication that builds benefits over weeks.

Primary Indications

Obsessive-Compulsive Disorder (OCD): Obsessions (intrusive thoughts) and compulsions (rituals) that feel hard to resistOCD-related anxiety and insomnia: When rumination and mental “loops” keep you stuck and wired at nightChronic anxiety states with obsessive features: When worry and checking/rumination overlap

Off-Label Uses

Panic disorderPosttraumatic stress disorder (PTSD)Social anxiety disorderGeneralized anxiety disorder (GAD)Major depressive disorder (MDD)Body dysmorphic disorderBulimia nervosaBinge eating disorder

What People Feel

Fluvoxamine isn’t like a benzo where you feel it in an hour. Most people describe a slow shift over time—often with a bumpy launch phase.

Early Weeks (Body Adjustment)

"The first week was weird—my stomach was loud and my sleep was off."

How Fast It Works

Fluvoxamine is not a fast-acting sedative. It’s a daily SSRI that gradually changes symptom intensity over time.

Days 1-7

Side effects can show up before benefits (nausea, sleep changes, jitteriness)

Week 1-2

Some people notice early shifts (slightly less rumination, less emotional reactivity)

Weeks 4-6

Where meaningful improvement often becomes obvious for many anxiety/depression patterns

Weeks 8-12

A more realistic “full trial” window for OCD/PTSD-style symptoms in many patients

Half-life ~14-16 hours (longer in older adults)

supports once- or twice-daily dosing depending on formulation and total dose

How Well It Works

Clinical response over time (not a PRN effect)

Not applicable for this medication.
vs Not applicable for this medication.
With fluvoxamine, the practical question isn’t “Does it work in 30 minutes?” It’s “Does it steadily reduce obsessions, compulsions, panic spirals, and anxiety intensity over weeks?” When it’s a good match, people often describe fewer intrusive loops, less urgency to ritualize, and more ability to let thoughts pass without acting on them.

Critical Safety Information

Critical Safety Information

Boxed warning: antidepressants can increase suicidal thinking/behavior in children, teens, and young adults early in treatment.
  • →If you’re under 25 (or caring for someone who is), take the boxed warning seriously: monitor mood, agitation, insomnia, impulsivity, and suicidal thoughts especially in the first 1-2 months or after dose changes.
  • →If you have bipolar history (or a family history), tell your clinician before starting. Antidepressants can flip the switch into hypomania/mania in vulnerable people.
  • →Know serotonin syndrome signs: severe agitation/confusion, tremor, sweating, diarrhea, muscle rigidity, fever. If that happens—urgent medical evaluation.
  • →If you bruise easily or take NSAIDs/blood thinners, bring it up. SSRIs can raise bleeding risk.
  • →Older adults: ask about sodium checks if you’re at risk for hyponatremia (fatigue, confusion, headache can be warning signs).
  • →Don’t stop suddenly if you’ve been on it for weeks—taper to reduce withdrawal symptoms.

Side Effects

Most common: nausea, insomnia or drowsiness, headache, dizziness, nervousness/jittery activation, and sexual side effects. Many early effects improve with time or a slower titration.

Common Things People Notice

  • Nausea (very common early on)
  • Insomnia or sleep disruption (also common), sometimes drowsiness instead
  • Headache and dizziness
  • Jittery/activated feeling (restlessness, anxiety spike) in sensitive patients
  • Dry mouth
  • Diarrhea
  • Sexual side effects (lower libido, delayed orgasm, erectile/ejaculatory issues)

Common Side Effects

Common (often reported early; nausea is frequently one of the top complaints)
Nausea / GI upset— This is the classic SSRI “startup tax.” It often improves over 1-2 weeks. Taking it with food (if tolerated) and starting low can help.
Common
Insomnia / Sleep disruption— Some people feel wired at night, especially early in treatment or after increases. If that’s you, dose timing and slower titration can make a big difference.
Common
Drowsiness / fatigue— Others get sleepy instead of wired. Bedtime dosing can help, and you should be careful with driving until you know your pattern.
Common
Nervousness / activation— This can look like anxiety, restlessness, jitteriness, or feeling overstimulated. It’s more likely if you start too high. Slower titration (even starting 25 mg) is a practical fix.
Common (varies widely)
Sexual dysfunction— Lower libido, delayed orgasm, or erectile/ejaculatory changes can show up within the first month. It’s common enough that it deserves upfront conversation, not a surprise later.
Common
Headache / dizziness— Usually improves with time. If dizziness is significant, check hydration, dose timing, and whether you’re combining with other meds that lower blood pressure.

⚠️ Serious Side Effects

  • Suicidal thinking/behavior in children, adolescents, and young adults early in treatment: urgent assessment if new or worsening suicidal thoughts occur.
  • Mania/hypomania or mixed symptoms: decreased need for sleep, racing thoughts, impulsivity, agitation—stop and evaluate for bipolar spectrum.
  • Serotonin syndrome: agitation/confusion, tremor, rigidity, fever, autonomic instability—medical emergency.
  • Severe hyponatremia/SIADH: confusion, severe headache, seizures—medical emergency (higher risk in older adults).
  • Clinically significant bleeding: GI bleeding or intracranial hemorrhage risk is higher when combined with NSAIDs/anticoagulants/antiplatelets.
  • Angle-closure glaucoma: eye pain/redness/vision changes—urgent ophthalmologic emergency.
  • Seizures: discontinue if seizures occur or frequency increases.

Critical Drug Interactions

Fluvoxamine is one of the most interaction-heavy SSRIs because it inhibits several CYP enzymes (especially CYP1A2 strongly, plus CYP2C19 moderately). Translation: it can raise levels of other meds in a way that matters clinically.

With: MAOIs, IV methylene blue (and other high-risk serotonergic combos)

Risk: Serotonin syndrome risk; some combinations are contraindicated.

Action: Do not combine. Allow at least 14 days between stopping an MAOI and starting fluvoxamine, and 14 days between stopping fluvoxamine and starting an MAOI.

With: Tizanidine

Risk: Contraindicated. Fluvoxamine can markedly increase tizanidine levels leading to profound hypotension and sedation.

Action: Avoid combination.

With: Thioridazine or pimozide

Risk: Contraindicated due to serious cardiac rhythm risk (QT prolongation/arrhythmia).

Action: Avoid combination.

With: Alosetron

Risk: Contraindicated due to increased drug levels/toxicity risk.

Action: Avoid combination.

With: NSAIDs, aspirin, antiplatelets, anticoagulants

Risk: Increased bleeding risk (bruising, GI bleed, rarely intracranial bleed).

Action: Use caution; consider GI protection in high-risk patients; monitor for bruising, black stools, vomiting blood, unusual bleeding.

With: Other serotonergic meds (triptans, SNRIs, other SSRIs, linezolid, tramadol, lithium, St. John’s wort, certain opioids)

Risk: Serotonin syndrome risk (usually low, but real).

Action: Avoid unnecessary serotonergic stacking; educate on symptoms; monitor especially during starts/increases.

With: Caffeine and other CYP1A2 substrates

Risk: Because fluvoxamine strongly inhibits CYP1A2, it can raise levels of CYP1A2-metabolized substances; caffeine sensitivity can spike (jitters, insomnia, palpitations).

Action: If you suddenly feel like caffeine hits you like a truck, cut down and reassess.

With: Smoking

Risk: Smoking may lower fluvoxamine levels; quitting smoking can shift levels upward over time.

Action: Tell your prescriber if smoking status changes so dosing and side effects can be reassessed.

Safe Discontinuation

Fluvoxamine can cause discontinuation symptoms if stopped abruptly—especially after being on it for a month or more. The move is a taper, not a cliff jump.

Key Points

  • If you’ve been on it ≥4 weeks: taper gradually over about 2 to 4 weeks as a common starting point (longer if high dose, long-term use, or prior withdrawal symptoms).
  • Brief treatment (2 to 3 weeks): taper over ~1 to 2 weeks may be reasonable.
  • <2 weeks: many people don’t need a taper, but sensitive patients can still feel it—use clinical judgment.
  • Withdrawal symptoms can include dizziness, “electric shock” sensations, nausea, tremor, anxiety, irritability, insomnia, and mood swings.
  • If withdrawal becomes intolerable: go back to the last tolerated dose, then taper more slowly.
  • Long-term treatment (>6 months): some patients do better with a very slow taper (months), especially if they’ve had rough withdrawals in the past.

Dosing Information

Adult Dosing

ocd ir initial: 50 mg PO at bedtime

ocd ir titration: Increase by 50 mg increments at intervals of at least 4 days as tolerated; divide total daily doses >100 mg/day into 2 doses

ocd ir typical: 100-300 mg/day (split if >100 mg/day)

ocd ir max: 300 mg/day (some experts may use up to 450 mg/day in select patients when well-tolerated but ineffective)

ocd er initial: 100 mg PO at bedtime

ocd er titration: Increase by 50 mg increments at intervals of at least 1 week as tolerated

ocd er typical: 100-300 mg once daily

ocd er max: 300 mg/day (some experts may use up to 450 mg/day in select patients when well-tolerated but ineffective)

gad initial: 50 mg PO once daily

gad titration: Increase in 25-50 mg increments based on response and tolerability at intervals of at least 3 days up to 100 mg/day; after 4-6 weeks may continue increasing by 50 mg every 1-2 weeks; divide doses >100 mg/day into 2 doses

gad max: 300 mg/day

panic initial: 25-50 mg PO once daily

panic titration: Increase gradually based on response and tolerability; some experts hold the lower end of the range for ~4 weeks before pushing higher; divide doses >100 mg/day into 2 doses

panic typical: 100-200 mg/day

panic max: 300 mg/day

ptsd initial: 25 mg PO twice daily OR 50 mg PO once daily

ptsd titration: Increase by 25-50 mg weekly based on response and tolerability; target 100-300 mg/day in 2 divided doses

ptsd max: 300 mg/day

social anxiety ir initial: 50 mg PO once daily

social anxiety ir titration: After 4-6 weeks at 50 mg/day, may increase by 50 mg at intervals of at least 1 week; divide doses >100 mg/day into 2 doses

social anxiety ir typical: 100-300 mg/day

social anxiety ir max: 300 mg/day

social anxiety er initial: 100 mg PO at bedtime

social anxiety er titration: After 4-6 weeks at 100 mg/day, may increase by 50 mg at intervals of at least 1 week

social anxiety er typical: 100-300 mg once daily

social anxiety er max: 300 mg/day

mdd initial: 50 mg PO once daily

mdd titration: Increase based on response and tolerability to 100-200 mg/day; divide doses >100 mg/day into 2 doses

mdd typical: 100-200 mg/day

mdd max: 300 mg/day (studied)

bdd initial: 50 mg PO once daily

bdd titration: Increase by 50 mg every 2-3 weeks based on response and tolerability; usual target 300 mg/day by weeks 6-10 (divide if >100 mg/day)

bdd typical: 300 mg/day

bdd max: 300 mg/day (some patients may require up to 450 mg/day if tolerated; adequate trial often 12-16 weeks with time at 300 mg/day if needed)

bulimia initial: 50 mg PO once daily

bulimia titration: Increase based on response and tolerability up to 300 mg/day; divide doses >100 mg/day into 2 doses

bulimia max: 300 mg/day

binge eating initial: 50 mg PO once daily

binge eating titration: Increase based on response and tolerability up to 300 mg/day; divide doses >100 mg/day into 2 doses (some trials used 3 divided doses at 300 mg/day)

binge eating max: 300 mg/day

expert low start option: Some experts start 25 mg PO daily and titrate slowly in ≤25 mg increments for anxiety-sensitive patients (activation, insomnia, nausea, dizziness, headache).

Simple Explanation

Fluvoxamine is usually a start-low, go-slow SSRI—especially in anxiety-sensitive people. Bedtime dosing often improves tolerability. For immediate-release tablets, once you go above 100 mg/day, splitting into two doses is common to reduce side effects and keep levels steadier. ER can be used once you’ve found a stable daily dose.

Pregnancy, Breastfeeding, Special Groups

Fluvoxamine can be used in special populations, but risk/benefit decisions matter—especially in pregnancy, breastfeeding, and older adults. In kids, immediate-release is approved for OCD (ages 8-17), but not for other pediatric indications.

👶Pregnancy

SSRIs as a class have extensive pregnancy data. Fluvoxamine crosses the placenta. Late-pregnancy SSRI exposure can be associated with neonatal adaptation symptoms (usually resolving within ~2 weeks) and a rare risk of persistent pulmonary hypertension of the newborn (PPHN). Dose reduction or discontinuation right before delivery to prevent neonatal adaptation syndrome is not recommended. Untreated depression/anxiety/OCD/PTSD in pregnancy also carries real risks (preterm birth, low birth weight, postpartum depression, impaired bonding), so treatment should be individualized using shared decision-making. If treatment-naïve in pregnancy, some guidelines prefer SSRIs other than fluvoxamine; if someone is stable and doing well on fluvoxamine, continuation may be reasonable unless contraindications exist.

🤱Breastfeeding

Fluvoxamine is present in breast milk and reported relative infant doses are generally low (often <2%). Many sources consider breastfeeding acceptable when RID is <10% (some are more conservative for psych meds). Most reported cases do not show adverse outcomes, but infants should be monitored for irritability, sleep changes, feeding issues, GI symptoms, and normal growth/development. If a breastfeeding infant develops symptoms soon after initiation or dose increase, reassess exposure and consider switching strategies.

👧Children & Adolescents (Under 18)

Immediate-release fluvoxamine is approved for OCD in pediatric patients 8 to 17 years. It is not approved for pediatric use outside OCD, and extended-release has not been evaluated in pediatric patients. Children 8-12 years often have higher exposure (AUC/Cmax), so titration may need to be more conservative.

👴Older Adults (65+)

Use with caution and consider lower starting doses with slower titration. Older adults have reduced clearance and higher plasma concentrations, and SSRIs are listed in the Beers Criteria to use with caution due to risk of SIADH/hyponatremia. Monitor sodium closely when initiating or adjusting dose, especially if risk factors are present.

🔬Liver Impairment

Use lower initial doses and titrate slowly; clearance is reduced and levels can rise. Some experts recommend a maximum of 150 mg/day in moderate to severe hepatic impairment.

💧Kidney Impairment

No dosage adjustment necessary for any degree of kidney impairment; limited excretion of unchanged drug by the kidney. Hemodialysis is only slightly effective for removal and no supplemental dose is generally needed.

Clinical Monitoring

  • Mental status and safety: clinical worsening, suicidality, or unusual behavior changes (anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania/mania), especially during the first 1-2 months and after dose changes.
  • Activation vs sedation: restlessness/jitteriness or daytime drowsiness—adjust dose timing and titration speed accordingly.
  • Serum sodium in at-risk populations (older adults, diuretic use, low baseline sodium, low body weight): check as clinically indicated, especially after initiation or dose increases.
  • Weight and BMI: appetite changes, weight gain/loss over time; track trends rather than one-off readings.
  • Sexual side effects: libido, orgasm, erectile/ejaculatory function—ask directly because patients often don’t volunteer it.
  • Bleeding/bruising: especially if combined with NSAIDs, aspirin, antiplatelets, or anticoagulants; monitor for GI bleed warning signs.
  • Liver function tests: baseline and as clinically indicated, especially in hepatic impairment or when pushing doses.
  • Akathisia: inner restlessness that can worsen anxiety and can be associated with suicidality risk—screen for it explicitly.
  • Drug interaction surveillance: review med list for CYP interactions and serotonergic stacking at every visit.
  • Functional outcomes: is OCD ritual time decreasing? are panic spirals shortening? is sleep stabilizing? are you functioning better at work/school/relationships?

Available Formulations

  • Immediate-Release Tablets (as maleate): 25 mg, 50 mg, 100 mg
  • Extended-Release Capsules 24 hour (as maleate): 100 mg, 150 mg
  • IR dosing note: Total daily doses >100 mg/day are typically divided into twice-daily dosing
  • Administration: May be taken with or without food; swallow ER capsules whole (do not crush/open/chew)

Mechanism of Action

Fluvoxamine is an SSRI: it blocks serotonin reuptake in the brain, increasing serotonin signaling over time. It has minimal direct effect on norepinephrine or dopamine reuptake and does not significantly bind alpha-adrenergic, histamine, or cholinergic receptors—so it’s not typically an antihistamine-sedation type antidepressant. Clinically, the benefit comes from gradual changes in anxiety circuitry and obsessive/intrusive thought patterns over weeks.

Place in Treatment Algorithm

Fluvoxamine is a core SSRI option for OCD, often paired with CBT/ERP for best outcomes. For anxiety disorders (panic, social anxiety, PTSD, GAD), it’s an off-label SSRI option—useful when intrusive/obsessive features overlap or when other SSRIs aren’t a fit. The two big practical considerations are (1) titration: start low and go slow to avoid activation, and (2) interactions: fluvoxamine inhibits multiple CYP enzymes, so medication reconciliation is not optional—it’s the whole game. It’s not a PRN med, and it’s not the right tool when someone needs immediate sedation or rapid symptom shutoff.

Not applicable for this medication.

Not applicable for this medication.

Not applicable for this medication.

Not applicable for this medication.

Not applicable for this medication.

Not applicable for this medication.

Frequently Asked Questions

What is fluvoxamine used for in psychiatry?

Its main lane is OCD—obsessions and compulsions. It’s also used off-label for anxiety-spectrum problems like panic disorder, social anxiety, PTSD, and sometimes GAD or depression. It’s a daily medication, not a quick “take it when I’m anxious” medication.

How long does fluvoxamine take to work?

Most people don’t feel a clean benefit in the first few days. Early changes can show up around 1-2 weeks, with more meaningful improvement around 4-6 weeks. OCD and PTSD-style symptoms often need a longer runway—sometimes up to 8-12 weeks for a fair trial, especially if dose increases are needed.

Does fluvoxamine help with anxiety or panic?

It can, especially when anxiety is tied to intrusive thoughts, rumination, or OCD-spectrum patterns. For panic, some people do well on it, but starting too high can feel like panic (jittery activation), so slow titration matters.

What are the most common side effects?

Nausea and GI upset are common early. Sleep can go either direction (insomnia or sleepiness). Headache, dizziness, and nervousness/activation can show up—especially if you ramp too fast. Sexual side effects are also common with SSRIs.

Can fluvoxamine make anxiety worse at first?

Yes—some people get early activation: jitteriness, restlessness, insomnia, or a spike in anxiety. That doesn’t mean it “failed”; it often means the start dose or titration was too aggressive. A lower start (even 25 mg) and slower increases can fix this.

What’s the suicidality warning about?

All antidepressants carry a boxed warning: in short-term studies, people under 25 had a higher risk of suicidal thinking/behavior compared with placebo early in treatment. That’s why clinicians monitor closely during the first 1-2 months and after dose changes. In adults over 24, that short-term increased risk wasn’t seen, and in adults 65+ there was a reduced risk compared with placebo.

Can fluvoxamine trigger mania?

It can—like other antidepressants, it may trigger hypomania/mania or mixed symptoms in people with bipolar vulnerability. If you notice decreased need for sleep, racing thoughts, impulsivity, or agitation that feels different from baseline anxiety, that’s an urgent conversation.

Why does fluvoxamine have so many drug interactions?

Because it inhibits multiple liver enzymes (especially CYP1A2, and also CYP2C19). That can raise levels of other medications. It’s one of the more interaction-heavy SSRIs, so medication review is essential.

How do I taper off fluvoxamine safely?

If you’ve been on it for a month or more, don’t stop abruptly. A common approach is tapering over 2-4 weeks, slower if you’re on higher doses, have been on it long-term, or have a history of withdrawal symptoms. If withdrawal hits hard, you typically go back to the last tolerated dose and taper more slowly.

Is fluvoxamine safe in pregnancy or breastfeeding?

This is a risk/benefit decision. SSRIs have extensive pregnancy data as a class. Late-pregnancy exposure can be associated with neonatal adaptation symptoms and a rare PPHN risk, but untreated depression/anxiety/OCD/PTSD also carries meaningful risks. In breastfeeding, fluvoxamine levels in milk are usually low, and many cases do fine, but infants should be monitored for irritability, sleep/feeding changes, and normal growth/development.

IR vs ER: what’s the difference?

Immediate-release tablets are often started first and may be split into twice-daily dosing when total daily doses go above 100 mg. Extended-release capsules are taken once daily and must be swallowed whole. Many clinicians use IR to find a stable effective daily dose, then switch to ER at the same total mg dose if it makes sense.

This medication information is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Never take medication without a prescription from a licensed healthcare provider.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists